A high-throughput approach towards a novel formulation of fenofibrate in omega-3 oil

European Journal of Pharmaceutical Sciences

Volumn 33, Issue 4-5, 2008, Pages 351-360

  Ratanabanangkoon, Pasut ^a   Guzman, Hector ^a   Almarsson, Orn ^a   Berkovitz, Dina ^a   Tokarcyzk, Stephanie ^a   Straughn, Arthur B ^b   Chen, Hongming ^a  

^a TransForm Pharmaceuticals Inc   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Fenofibrate; High throughput screening (HTS); Lipid formulation; Omega 3; Self emulsifying drug delivery systems (SEDDS)

Indexed keywords

FENOFIBRATE; OMEGA 3 FATTY ACID;

ARTICLE; DRUG FORMULATION; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANTILIPEMIC AGENTS; AREA UNDER CURVE; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; EXCIPIENTS; FATTY ACIDS, OMEGA-3; HALF-LIFE; HUMANS; MOLECULAR STRUCTURE; PROCETOFEN; SOLUBILITY;

EID: 41349115243     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2008.01.005     Document Type: Article

References (13)

1. Ascherio A., Rimm E.B., Stampfer M.J., Giovannucci E.L., and Willett W.C. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. NEJM 332 15 (1995) 977-982
2. Bailer A.J. Testing for the equality of area under the curves when using destructive measurement techniques. J. Pharmacokinet. Biopharm. 16 (1988) 303-309
3. Constantinides P.P. Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res. 12 (1995) 1561-1572
4. Daviglus M.L., Stamler J., Orencia A.J., Dyer A.R., Liu K., Greenland P., Walsh M.K., Morris D., and Shekelle R.B. Fish consumption and the 30-year risk of fatal myocardial infarction. NEJM 336 15 (1997) 1046-1053
5. Dressman J.B., Amidon G.L., Reppas C., and Shah V.P. Dissolution as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm. Res. 15 (1998) 11-22
6. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354 (1999) 447-455
7. Harper C.R., and Jacobson T.A. Usefulness of omega-3 fatty acids and the prevention of coronary heart disease. Am. J. Cardiol. 96 11 (2005) 1521-1529
8. Holmberg K., Jönsson B., Kronberg B., and Lindman B. Surfactants and Polymers in Aqueous Solution. 2nd ed. (2003), Wiley, New York
9. Humberstone A.J., and Charman W.N. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv. Drug Deliv. Rev. 25 (1997) 103-128
10. Krauss R.M., Eckel R.H., Howard B., Appel L.J., Daniels S.R., Deckelbaum R.J., Erdman J.W., Kris-Etherton P., Goldberg I.J., Kotchen T.A., Lichtenstein A.H., Mitch W.E., Mullis R., Robinson K., Wylie-Rosett J., Jeor S.St., Suttie J., Tribble D.L., and Bazzarre T.L. AHA dietary guidelines revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102 (2000) 2296-2311
11. Pouton C.W. Formulation of self-emulsifying drug delivery systems. Adv. Drug Deliv. Rev. 25 (1997) 47-58
12. Pouton C.W. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying, and "self-microemulsifying" drug delivery systems. Eur. J. Pharm. Sci. 11 2 (2000) S93-S98
13. Rosen M.J. Surfactants and Interfacial Phenomena. 2nd ed. (1989), Wiley, New York